| Market Capitalization (Millions $) |
103 |
| Shares
Outstanding (Millions) |
27 |
| Employees |
66 |
| Revenues (TTM) (Millions $) |
19 |
| Net Income (TTM) (Millions $) |
-5 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
1 |
Business Description
ICAD Inc. is a medical technology company headquartered in Nashua, New Hampshire. The company specializes in developing advanced cancer detection and radiation therapy treatment solutions. It primarily focuses on products and services related to improving cancer detection accuracy and treatment outcomes.
One of the major innovations offered by ICAD Inc. is its advanced imaging technology called PowerLook® TomoDetection™. This technology assists radiologists in identifying potential abnormal tissues in breast images with greater accuracy and efficiency, aiding in early detection of breast cancer.
ICAD Inc. is also known for its Xoft® Axxent® Electronic Brachytherapy (eBx®) System®, which offers a non-invasive and targeted radiation therapy solution for various types of cancer treatments, including breast, skin, and gynecological cancers. The system is designed to provide precise and localized radiation treatment, reducing potential side effects and improving patient comfort.
Overall, ICAD Inc. is dedicated to advancing the field of cancer detection and radiation therapy by providing cutting-edge technology solutions that enhance patient care and improve overall treatment outcomes.
Company Address: 2 Townsend West, Suite 6 Nashua 3063 NH
Company Phone Number: 882-5200 Stock Exchange / Ticker: NASDAQ ICAD
|
2.05% 
76.14 %